JPMorgan Chase & Co’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78K | Sell |
983
-4,742
| -83% | -$32.7K | ﹤0.01% | 5498 |
|
|
2025
Q1 | $30.4K | Buy |
5,725
+448
| +8% | +$2.38K | ﹤0.01% | 5170 |
|
|
2024
Q4 | $62.3K | Sell |
5,277
-230
| -4% | -$2.71K | ﹤0.01% | 4939 |
|
|
2024
Q3 | $114K | Buy |
5,507
+1,172
| +27% | +$24.2K | ﹤0.01% | 4673 |
|
|
2024
Q2 | $196K | Sell |
4,335
-57,219
| -93% | -$2.59M | ﹤0.01% | 4285 |
|
|
2024
Q1 | $2.42M | Buy |
61,554
+61,011
| +11,236% | +$2.39M | ﹤0.01% | 3039 |
|
|
2023
Q4 | $3.28K | Sell |
543
-1,163
| -68% | -$7.03K | ﹤0.01% | 5606 |
|
|
2023
Q3 | $11.5K | Buy |
1,706
+1,519
| +812% | +$10.2K | ﹤0.01% | 5277 |
|
|
2023
Q2 | $1.47K | Sell |
187
-6
| -3% | -$47 | ﹤0.01% | 5487 |
|
|
2023
Q1 | $1K | Sell |
193
-1,254
| -87% | -$6.5K | ﹤0.01% | 5633 |
|
|
2022
Q4 | $5K | Sell |
1,447
-19
| -1% | -$66 | ﹤0.01% | 5211 |
|
|
2022
Q3 | $7K | Sell |
1,466
-323
| -18% | -$1.54K | ﹤0.01% | 5120 |
|
|
2022
Q2 | $14K | Sell |
1,789
-1,649
| -48% | -$12.9K | ﹤0.01% | 5115 |
|
|
2022
Q1 | $55K | Sell |
3,438
-148
| -4% | -$2.37K | ﹤0.01% | 4982 |
|
|
2021
Q4 | $66K | Buy |
3,586
+2,433
| +211% | +$44.8K | ﹤0.01% | 4981 |
|
|
2021
Q3 | $35K | Sell |
1,153
-5,089
| -82% | -$154K | ﹤0.01% | 5032 |
|
|
2021
Q2 | $342K | Sell |
6,242
-4,191
| -40% | -$230K | ﹤0.01% | 4214 |
|
|
2021
Q1 | $617K | Buy |
10,433
+1,797
| +21% | +$106K | ﹤0.01% | 3931 |
|
|
2020
Q4 | $323K | Buy |
8,636
+7,608
| +740% | +$285K | ﹤0.01% | 3976 |
|
|
2020
Q3 | $61K | Buy |
1,028
+252
| +32% | +$15K | ﹤0.01% | 4233 |
|
|
2020
Q2 | $195K | Sell |
776
-7,069
| -90% | -$1.78M | ﹤0.01% | 3679 |
|
|
2020
Q1 | $1.23M | Buy |
7,845
+1,819
| +30% | +$286K | ﹤0.01% | 2854 |
|
|
2019
Q4 | $987K | Buy |
6,026
+4,736
| +367% | +$776K | ﹤0.01% | 3089 |
|
|
2019
Q3 | $188K | Buy |
1,290
+648
| +101% | +$94.4K | ﹤0.01% | 3771 |
|
|
2019
Q2 | $132K | Buy |
642
+100
| +18% | +$20.6K | ﹤0.01% | 3919 |
|
|
2019
Q1 | $113K | Buy |
542
+117
| +28% | +$24.4K | ﹤0.01% | 3967 |
|
|
2018
Q4 | $74K | Buy |
425
+40
| +10% | +$6.97K | ﹤0.01% | 4141 |
|
|
2018
Q3 | $87K | Buy |
385
+47
| +14% | +$10.6K | ﹤0.01% | 4166 |
|
|
2018
Q2 | $51K | Buy |
338
+8
| +2% | +$1.21K | ﹤0.01% | 4306 |
|
|
2018
Q1 | $60K | Sell |
330
-19
| -5% | -$3.46K | ﹤0.01% | 4093 |
|
|
2017
Q4 | $74K | Buy |
+349
| New | +$74K | ﹤0.01% | 4008 |
|
|
2016
Q3 | – | Sell |
-33
| Closed | -$3K | – | 4102 |
|
|
2016
Q2 | $3K | Buy |
+33
| New | +$3K | ﹤0.01% | 4020 |
|